AxSpa Treatment Goals and Windows of Opportunity
March 28, 2019 – 
Hillary Norton, MD, considers the windows of opportunity in managing axial spondyloarthritis to prevent various comorbidities and discusses the goals of therapy.
 
Diagnosing Axial Spondyloarthritis
March 28, 2019 – 
Hillary Norton, MD, discusses the diagnosis of axial spondyloarthritis, namely the difficulties of accurate and timely identification, and considers possible comorbidities.
 
Advice for NrAxSpa Patients & Future of Treatment
March 21, 2019 – 
Tiffany Westrich-Robertson provides advice for people with nonradiographical axial spondyloarthritis, and considers the future of autoimmune and autoinflammatory treatment.

 
The Epidemiology of Axial Spondyloarthritis
March 21, 2019 – 
Hillary Norton, MD, discusses the epidemiology of axial spondyloarthritis.
Nonradiographic Versus Radiographic Axial Spondyloarthritis
March 21, 2019 – 
Hillary Norton, MD, considers the differences between nonradiographic and radiographic axial spondyloarthritis and discusses the impact of these diseases on everyday life.
The IFAA: Raising Awareness of NrAxSpa & Related Diseases
March 14, 2019 – 
Tiffany Westrich-Robertson provides an overview of the International Foundation for Autoimmune & Autoinflammatory Arthritis and discusses how it has affected patients with nonradiographical axial spondyloarthritis and related diseases.
Living With NrAxSpa Posttreatment
March 14, 2019 – 
Tiffany Westrich-Robertson discusses how certolizumab pegol has affected her day-to-day life.
 
The Impact of Certolizumab Pegol in Treating Nr-AxSpA
March 07, 2019 – 
Tiffany Westrich-Robertson considers how the process of identifying non-radiographical axial spondyloarthritis has changed over the years and emphasizes the importance of raising awareness of autoimmune and autoinflammatory diseases.
 
The Progression of Nr-AxSpA Symptoms
March 07, 2019 – 
Tiffany Westrich-Robertson considers the progression of her nonradiographic axial spondyloarthritis and how the worsening of her treatments have affected daily life.
Ineffective NrAxSpa Treatments
February 28, 2019 – 
Tiffany Westrich-Robertson provides insight into the various ineffective treatments she received prior to using the biologic therapy certolizumab pegol.
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.